Pancreatic and biliary diseases: Issues in hyperlipidemic pancreatitis

Journal of Clinical Gastroenterology

Volumn 36, Issue 1, 2003, Pages 54-62

  Yadav, Dhiraj ^a   Pitchumoni, C S ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b OUR LADY OF MERCY MEDICAL CENTER   (United States)

Author keywords

Hyperlipidemia; Hypertriglyceridemia; Pancreatitis

Indexed keywords

AMYLASE; BEZAFIBRATE; CIPROFIBRATE; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; ORAL CONTRACEPTIVE AGENT; STATINE DERIVATIVE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ALCOHOL CONSUMPTION; AMYLASE BLOOD LEVEL; CLINICAL FEATURE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EXTRACORPOREAL CIRCULATION; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; HUMAN; HYPERLIPIDEMIC PANCREATITIS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LOW FAT DIET; PANCREATITIS; PATHOGENESIS; PLASMAPHERESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ACUTE DISEASE; ALCOHOLISM; DIET; DIET SUPPLEMENTATION; ESTROGEN THERAPY; FEMALE; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; PATHOPHYSIOLOGY; PREGNANCY;

ACUTE DISEASE; ALCOHOLISM; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIET; DIETARY SUPPLEMENTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FISH OILS; HUMANS; HYPERLIPIDEMIAS; HYPERLIPOPROTEINEMIAS; PANCREATITIS; PREGNANCY; RECURRENCE;

EID: 0037209124     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200301000-00016     Document Type: Review

References (89)

1. Speck L. Fall von lipamia. Arch Verin Wissepischaftl Heilkunde 1865:1:232. Quoted in Thannhauser SJ, ed. Lipidoses, Diseases of the Intracellular Lipid Metabolism, 3rd Ed. New York: Grune & Stratton, 1958:307.
2. Speck L. Fall von lipamia. Arch Verin Wissepischaftl Heilkunde 1865:1:232. Quoted in Thannhauser SJ, ed. Lipidoses, Diseases of the Intracellular Lipid Metabolism, 3rd Ed. New York: Grune & Stratton, 1958:307.
3. Coffey RJ. Unusual features of pancreatic disease. Ann Surg 1952:135:715-20.
4. Wang C, Aldersberg D, Feldman EB. Serum lipids in acute pancreatitis. Gastroenterology 1959;36:832-40.
5. Greenberger NJ, Hatch FT, Drummey GD, et al. Pancreatitis and hyperlipidemia. Medicine 1966;45:161-75.
6. Farmer RG, Winkelmann EI, Brown HB, et al. Hyperlipoporteinemia and pancreatitis. Am J Med 1973;54:161-5.
7. Buch A, Buch J, Carlsen A, et al. Hyperlipidemia and pancreatitis. World J Surg 1980;4:307-14.
8. Dickson AP, O'Neill J, Imrie CW. Hyperlipidemia, alcohol abuse and acute pancreatitis. Br J Surg 1984;:71:685-8.
9. Dominguez-Munoz JE, Malfertheiner P, Ditschhneit HH, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset and severity of the disease. Int J Pancreatol 1991; 10:261-7.
10. Cameron JL, Capuzzi DM, Zuidema GD, et al. Acute pancreatitis with hyperlipiemia: The incidence of lipid abnormalities in acute pancreatitis. Ann Surg 1973;177:493-9.
11. Miller A, Lees RS, McCluskey MA, et al. The natural history and surgical significance of hyperlipemic abdominal crisis. Ann Surg 1979; 190:401-8.
12. Greenberg BH, Blackwelder WC, Levy RL. Primary type-V hyperlipoproteinemia. A descriptive study in 32 families. Ann Intern Med 1977;87:526-34.
13. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990;19:783-91.
14. Liu Q, Prinz RA. Pancreatitis associated with hyperlipidemia and hyperparathyroidism. In: Howard JM, Idezuki Y, lhse I, et al., eds. Surgical Diseases of the Pancreas, 3rd Ed. Baltimore, Williams & Wilkins, 1998:271-80.
15. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ, ed. Blood Lipids and Lipoproteins: Quantification, Composition and Metabolism. New York: John Wiley & Sons, 1972:181.
16. , Nilsson-Ehle P. Regulation of lipoprotein lipase: Triacylglycerol transport in plasma. In: Carlson LA, Pernow B, eds. Metabolic Risk Factors in Ischemic Cardiovascular Disease. New York, Raven Press, 1982:49.
17. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992;37:249-73.
18. Fortson MR, Freedman SN, Webster PD., Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995;90:2134-9.
19. Brunzell JD, Bierman EL. Chylomicronemia syndrome. Med Clin N Am 1982; 66:455-8.
20. Cameron JL, Capuzzi DM, Zuidema GD, et al. Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism. Am J Med 1974:56:482-7.
21. Fallat RW, Vester JW, Glueck CJ. Supression of amylase activity by hypertriglyceridemia. JAMA 1973:225:1331-4.
22. Lesser PB, Warshaw AL. Diagnosis of pancreatitis masked by hyperlipemia. Ann Intern Med 1975;82:795-8.
23. Warshaw AL, Bellini CA, Lesser PB. Inhibition of serum and urine amylase activity in pancreatitis with hyperlipemia. Ann Surg 1975; 182:72-5.
24. Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med 1969;15:117-54.
25. Saharia P, Margolis S. Zuidema MD, et al. Acute pancreatitis with hyperlipidemia: Studies with an isolated perfused canine pancreas. Surgery 1977;82:60-7.
26. Fredrickson DS. Levy RI, Lees RS: Fat transport in lipoproteins: An integrated approach to mechanisms and disorders. N Engl J Med 1967;276:34-44.
27. Bushy-Whitehead MJ, Blackman MR. Clinical implications of abnormal lipoprotein metabolism. In: Barker LR, Burton JR, Zieve PD, eds. Principles of Ambulatory Medicine, 5th Ed. Baltimore, Williams & Wilkins, 1999:1122-49.
28. Chait A, Brunzell JD. Severe HTG. Role of familial and acquired disorders. Metabolism 1983:32:209-13.
29. Ginsberg H, Olefsky J, Farquhar JW, et al. Moderate ethanol ingestion and plasma triglyceride levels: A study in normal and hypertriglyceridemic persons. Ann Intern Med 1974:80:143-9.
30. Cameron JL, Zuidema GD, Margolis S. A pathogenesis of alcoholic pancreatitis. Surgery 1975;77:754-63.
31. Erkelens W, Brunzell JD. Effect of controlled alcohol feeding on triglycerides in patients with outpatient "alcohol hypertriglyceridemia. " J Hum Nutr 1980;34:370-5.
32. Pownall HJ, Ballantyne C, Kimball K, et al. Effect of moderate alcohol consumption on HTG: A study in the fasting state. Arch Intern Med 1999;159:981-7.
33. Pownwall HJ. Dietary alcohol is associated with reduced lipolysis of internally derived lipoproteins. J Lipid Res 1994;35:2105-13.
34. Taskinen MR, Valimaki M, Nikkila EA, et al. Sequence of alcohol induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans. Metabolism 1985;34:112-9.
35. Havel RJ. Approach to the patient with hyperlipidemia. Med Clin North Am 1982;66:319-33.
36. Nair S, Yadav, D, Pitchumoni, CS. Association of Diabetic Ketoacidosis and Acute Pancreatitis: Observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000;95:2795-800.
37. Hazzard WR, Spiger MJ, Bagdade JD, et al. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med 1969:280:471-4.
38. Knopp RH, Walden CE, Wahl PW, et al. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: Relationship to estrogen and progestin potency. J Clin Endocrinol Metab 1981;53:1123-32.
39. Glueck CJ, Scheel D, Fiskback J, et al. Estrogen-induced pancreatitis in patients with previously covert Familial type V hyperlipoproteinemia. Metabolism 1972; 21:657-66.
40. Glueck CJ, Lang J, Hames T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement is given to hypertriglyceridemic women. J Lab Clin Med 1994;123:59-64.
41. Crook D, Cust MP, Ganger KF, et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: Effect on serum lipids and lipoproteins. Am J Obstet Gynaecol 1992; 166:950-5.
42. De Chalain TMB, Michell WL, Berger GMB. Hyperlipidemia, pregnancy and pancreatitis. Surg Gynaecol Obstet 1988;167:469-73.
43. Gleuck CJ, Christopher C, Mishkel MA, et al. Pancreatitis, familial HTG and pregnancy. Am J Obstet Gynecaol 1980;136:755-61.
44. Herrera E, Gomez-Coronado D, Lascuncion MA. Lipid metabolism in pregnancy. Biol Neonate 1987;57:70-7.
45. Herrera E, Lascuncion MA, Gomez-Coronado D, et al. Role of lipoprotein-lipase activity on lipoprotein metabolism on fate of circulating triglycerides in pregnancy. Am J Obstet Gynaecol 1988; 158:1575-83.
46. Bershad S, Rubinstein A, Paterniti JR, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 1985;313:981-5.
47. Flynn WJ, Freemann PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced HTG. Ann Intern Med 1987;107:63.
48. Noguchi M, Taniya T, Tajiri K, et al. Fatal hyperlipidemia in a case of metastatic breast cancer treated by tamoxifen. Br J Surg 1987;74:586-7.
49. Lasser NL, Grandits G, Caggiula AW, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am J Med 1984:76:52-66.
50. Lardinos CK, Neuman SL. The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med 1988:148:1280-8.
51. Echevarria KL. Hardin TC, Smith JA. Hyperlipidemia associated with protease inhibitor therapy. Ann Pharmacother 1999; 33:859-63.
52. Kumar AN, Schwartz DE, Lim KG. Propofol-induced pancreatitis: Recurrence after rechallenge. Chest 1999;115:1198-9.
53. Hofbauer B, Friess H, Weber A, et al. Hyperlipemia intensifies the course of acute oedematous and acute necrotizing pancreatitis in the rat. Gut 1996;38:753-8.
54. Haig THB. Experimental pancreatitis intensified by a high fat diet. Surg Gynecol Obstet 1970;131:914-8.
55. Warshaw AL, Lesser PB, Rie M, et al. The pathogenesis of pulmonary edema in acute pancreatitis. Ann Surg 1975;182:505-10.
56. Kimura T, Toung JK, Margolis S, et al. Respiratory failure in acute pancreatitis. A possible role for triglycerides. Ann Surg 1979;189:509-14.
57. Athyros V, Gioulene OI, Nikolaidis NL, et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002; 34:472-5.
58. Hacken JB, Moccia RM. Calcific pancreatitis in a patient with type 5 hyperlipoproteinemia. Gastrointestinal Radiol 1979;4:143-6.
59. Krauss RM, Levy AG. Subclinical chronic pancreatitis in type I hyperlipoproteinemia. Am J Med 1977:62:1449.
60. Guzman S, Nervi F, Llanos O, et al. Impaired lipid clearance in patients with previous acute pancreatitis. Gut 1985;26:888-9.
61. Haber PS, Wilson JS, Apte MV, et al. Lipid intolerance does not account for susceptibility to alcohol and gallstone pancreatitis. Gastroenterology 1994;106:742-8.
62. Durrington PN, Twentyman OP, Braganza JM, et al. HTG and laboratory abnormalities of triglyceride catabolism persisting after pancreatitis. Int J Pancreatol 1986; 1:195-203.
63. Dominguez-Munoz JE, Junemann F, Malfertheiner P. Hyperlipidemia in acute pancreatitis. Cause or epiphenomenona? Int J Pancreatol 1995;18:101-6.
64. Fojo SS, Brewer HB. Hypertriglyceridemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992; 23:669-77.
65. Fojo SS, Brewer HB Jr. The familial hyperchylomicronemia syndrome. JAMA 1991;265:904-8.
66. Chait A, Mancini M, February AW, et al. Clinical and metabolic study of alcoholic hyperlipemia. Lancet 1974;2:62-4.
67. De Mann FH, van der Laarse A, Hopman EG, et al. Dietary counseling effectively improves lipid levels in patients with endogenous hypertriglyceridemia: Emphasis on weight reduction and alcohol limitation. Eur J Clin Nutr 1999;53:413-8.
68. Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA study, protocol 1. Arterioscler Thromb Vaszc Biol 1998;18:441-9.
69. Kris-Etherton PM, Pearson TA, Wan Y, et al. High-monounsaturated fatty acids lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 1999;70:1009-15.
70. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis. Am J Clin Nutr 1992;56:320-8.
71. Yu-Poth S, Zhao G, Etherton T, et al. Effects of the National Cholesterol Education Program's Step I and II dietary intervention programs on cardiovascular disease risk factors: A meta analysis. Am J Clin Nutr 1999;69; 632-46.
72. Santamarina-Fojo S,. Brewer HB. The familial hyperchylomicronemia syndrome: New insights into underlying genetic defects. JAMA 1991;265:9048.
73. Harris WS. N-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997;65(suppl. 5):1645s-54s.
74. Connor WE, DeFrancesco CA, Connor SL. N-3 fatty acids from fish oil: Effects on plasma lipoproteins and hypertriglyceridemic patients. Ann N Y Acad Sci 1993;683:16-34.
75. Harris WS, Rothrock DW, Fanning A, et al. Fish oils in hypertriglyceridemia: A dose-response study. Am J Clin Nutr 1990;51:399-406.
76. Rambjor GS, Walen Al, Windsor SL. et al. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 1996; 31:S45-9.
77. Harris WS. Fish oils and lipoprotein metabolism in humans. J Lipid Res 1989: 30:785-807.
78. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: Primary prevention with gemfibrozil in middle aged men with dyslipidemia. N Engl J Med 1987;317:1237-45.
79. Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-93.
80. Gang N, Langevitz P, Livneh A. Relapsing acute pancreatitis induced by re-exposure to the cholesterol lowering agent bezafibrate. Am J Gastroenterol 1999:94:3626-8.
81. Abdul-Ghaffar NU, el-Sonabaty MR. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy. J Clin Gastroenterol 1995;21:340-1.
82. Ayanian JZ. Fuchs CS, Stone RM. Lovastatin and rhabdomyolysis. Ann Intern Med 1988;109:682-3.
83. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990;264:71-5.
84. Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, et al. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. Am J Cardiol 1997;80:608-13.
85. Heaney AP, Sharer N, Rameh B, et al. Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy. J Clin Endocrin Metabol 1999;84:1203-5.
86. Piolot A, Nadler F, Cavallero E, et al. Prevention of recurrent acute pancreatitis in patients with severe HTG: Value of regular plasmapheresis. Pancreas 1996; 13:96-9.
87. Archad JM, Westeel PF, Moriniere JD, et al. Pancreatitis related to severe acute HTG during pregnancy: Treatment with lipoprotein apheresis. Intensive Care Med 1991;17:236-7.
88. Roberts IM. Hypedipidemic gestational pancreatitis. Gastroenterology 1993; 104:1560-2.
89. Swoboda K, Derfler K, Koppensteiner R, et al. Extracorporeal lipid elimination for treatment of gestational hyperlipidemic pancreatitis. Gastroenterology 1993;104:527-31.